Krisstina Gowin is a Hematology physician affiliated with City Of Hope National Medical Center. OpenAlex indexes 94 publications with 1,351 citations (h-index 16); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1000 Fivepoint
Irvine, CA 926182377
Telephone
888-333-4673Provider last certified this registry record 1 May 2025.
Clinical trials
- The TOTOM Trial: Tai Chi to Optimize Transplant Outcomes for Multiple Myeloma
Sponsor: University of Arizona
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20241 payment
- Genentech USA, Inc.Program year20241 payment
- GlaxoSmithKline, LLC.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
45%Thalidomide Analog26.4%Revlimid75%Pomalyst14%Lenalidomide11%Part D<11 patientsAntimetabolite6.1%Hydroxyurea100%Part D≥11 patients+ 3 more classes in this area
Dermatology
20.7%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor20.7%Acyclovir100%Part D≥28 patientsNervous system
20.1%Opioid Agonist10.3%Morphine Sulfate Er41%Oxycodone Hcl37%Morphine Sulfate22%Part D<11 patientsGabapentinoids9.7%Gabapentin54%Pregabalin46%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Synthesis and Educational Overview of the ASCO–Society of Integrative Oncology Guidelines: On the Path to Implementation
American Society of Clinical Oncology Educational Book
2025 - Artificial Intelligence in Supportive Oncology and Symptom Management Opportunities
The Cancer Journal
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Erminia Massarelli, MD
City Of Hope National Medical Center
Swetha Thiruvengadam, MD
City Of Hope National Medical Center
Yuman Fong, MD
City Of Hope National Medical Center
Ravi Salgia, MD, PhD
City Of Hope National Medical Center
Joseph Antin, MD
Harvard University
Scott Kaufmann, MD
Mayo Clinic College of Medicine
Jeffrey Miller, MD
University of Minnesota Medical School
Ruben Mesa, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”